X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1603) 1603
Newspaper Article (110) 110
Newsletter (62) 62
Transcript (18) 18
Book Chapter (11) 11
Magazine Article (6) 6
Dissertation (4) 4
Publication (2) 2
Reference (2) 2
Conference Proceeding (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
fulvestrant (1743) 1743
science & technology (1000) 1000
life sciences & biomedicine (941) 941
breast cancer (878) 878
humans (759) 759
estradiol - analogs & derivatives (744) 744
female (724) 724
estradiol - pharmacology (537) 537
oncology (535) 535
breast neoplasms - drug therapy (409) 409
estrogen (400) 400
animals (396) 396
cancer (382) 382
estrogen antagonists - pharmacology (313) 313
research (280) 280
care and treatment (268) 268
metastasis (256) 256
receptors, estrogen - metabolism (256) 256
breast neoplasms - pathology (242) 242
tamoxifen (227) 227
health aspects (215) 215
endocrine therapy (212) 212
breast neoplasms - metabolism (207) 207
estradiol - therapeutic use (172) 172
tamoxifen - pharmacology (166) 166
middle aged (163) 163
tumors (158) 158
cell line, tumor (157) 157
phenols (157) 157
antineoplastic agents, hormonal - therapeutic use (153) 153
rats (153) 153
mice (150) 150
estrogen receptors (146) 146
analysis (143) 143
cancer therapies (143) 143
oncology, experimental (143) 143
aged (138) 138
women (137) 137
estrogen receptor (136) 136
biochemistry & molecular biology (131) 131
postmenopausal women (130) 130
breast neoplasms - genetics (129) 129
chemotherapy (125) 125
clinical trials (125) 125
drug therapy (123) 123
gene expression (122) 122
estrogens (120) 120
dose-response relationship, drug (119) 119
patients (119) 119
metastases (118) 118
tumor cells, cultured (116) 116
male (115) 115
endocrinology & metabolism (114) 114
medicine & public health (114) 114
adult (112) 112
hormones (112) 112
pharmacology & pharmacy (106) 106
postmenopause (100) 100
estradiol - administration & dosage (97) 97
estradiol (95) 95
treatment outcome (93) 93
kinases (91) 91
receptors, estrogen - antagonists & inhibitors (91) 91
signal transduction (91) 91
antineoplastic agents, hormonal - pharmacology (90) 90
receptors, estrogen - genetics (90) 90
estrogens - pharmacology (89) 89
mutation (88) 88
cell biology (87) 87
cell proliferation - drug effects (87) 87
erbb-2 protein (87) 87
estrogen receptor alpha - metabolism (87) 87
medical research (87) 87
anastrozole (84) 84
antineoplastic combined chemotherapy protocols - therapeutic use (82) 82
cells, cultured (82) 82
development and progression (82) 82
advanced breast cancer (81) 81
estrogen receptor modulators - pharmacology (81) 81
pharmaceutical industry (80) 80
epidermal growth factor (79) 79
drug resistance, neoplasm (78) 78
genetic aspects (77) 77
proteins (76) 76
apoptosis (75) 75
physical fitness (75) 75
cell cycle (73) 73
aged, 80 and over (72) 72
cell division - drug effects (72) 72
cell proliferation (70) 70
estradiol - adverse effects (70) 70
antineoplastic agents (67) 67
estrogen antagonists - therapeutic use (67) 67
rats, sprague-dawley (67) 67
cancer patients (66) 66
metastatic breast cancer (66) 66
research article (66) 66
blotting, western (64) 64
antimitotic agents (62) 62
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1791) 1791
Japanese (20) 20
German (6) 6
Russian (5) 5
French (4) 4
Hungarian (4) 4
Spanish (4) 4
Chinese (3) 3
Portuguese (2) 2
Czech (1) 1
Dutch (1) 1
Korean (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 03/2019, Volume 380, Issue 13, pp. 1226 - 1234
Journal Article
R and D focus drug news, ISSN 1350-1135, 09/2020
Journal Article
Women's health weekly, ISSN 1078-7240, 04/2020, p. 108
Journal Article
Journal Article
Breast cancer research and treatment, ISSN 0167-6806, 4/2018, Volume 168, Issue 3, pp. 639 - 647
Journal Article
Clinical cancer research, ISSN 1557-3265, 06/2016, Volume 22, Issue 24, pp. 6204 - 6216
Purpose: The conversion of tumor cells from an epithelial to a mesenchymal-like phenotype, via a process designated as the epithelial-mesenchymal transition... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Index Medicus | lung cancer | EMT | fulvestrant | brachyury | immune resistance
Journal Article
The New England journal of medicine, ISSN 1533-4406, 11/2018, Volume 379, Issue 20, pp. 1926 - 1936
Journal Article
The New England journal of medicine, ISSN 1533-4406, 02/2012, Volume 366, Issue 6, pp. 520 - 529
Resistance to hormone therapy through activation of cellular pathways involving mTOR can develop in postmenopausal hormone-receptor–positive breast cancer.... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Recurrence | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Bone Neoplasms - secondary | TOR Serine-Threonine Kinases - antagonists & inhibitors | Aromatase Inhibitors - adverse effects | Breast Neoplasms - chemistry | Aged, 80 and over | Postmenopause | Adult | Female | Aromatase Inhibitors - therapeutic use | Everolimus | Sirolimus - adverse effects | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Kaplan-Meier Estimate | Receptor, Epidermal Growth Factor - analysis | Breast Neoplasms - drug therapy | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Stomatitis - chemically induced | Aged | Androstadienes - therapeutic use | Androstadienes - adverse effects | Drugs | Care and treatment | Usage | Hormone therapy | Patient outcomes | Drug utilization | Breast cancer | Product/Service Evaluations | Drug therapy, Combination | Drug therapy | TOR protein | Anastrozole | Endocrine therapy | Fatigue | Intracellular signalling | Rapamycin | Tamoxifen | Cancer therapies | Survival | Post-menopause | Fulvestrant | Signal transduction | Stomatitis | Hyperglycemia | Chemotherapy | Pneumonitis | Dyspnea | Aromatase | Antitumor activity | Respiration | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2015, Volume 373, Issue 17, pp. 1672 - 1673
To the Editor: In the PALOMA3 study, Turner et al. (July 16 issue) 1 report that the addition of palbociclib to fulvestrant improved progression-free survival... 
Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Humans | Female | Piperazines - therapeutic use | Breast Neoplasms - drug therapy | Pyridines - therapeutic use | Breast cancer | Quality of life | Fulvestrant | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 07/2015, Volume 373, Issue 3, pp. 209 - 219
Journal Article